SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 4 — Focused Visit (Follow-up) — Frederick Cook — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientFrederick Cook
Date of birth1865-06-10
IdentifiersMRN HR-EX006-SYN-TD; SSN (made up) 000-06-4471
Document date1930-08-18
AuthorHarriet Okafor-Brandt, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Six-week review of blood pressure, electrolytes and kidney function four weeks after starting hydrochlorothiazide and amlodipine. [S]

History of Present Illness

Mr. Cook returns four weeks after starting hydrochlorothiazide 25 mg, amlodipine 5 mg, atorvastatin 40 mg and aspirin 81 mg. He has missed no doses. He urinates more in the mornings but has no dizziness on standing, cramps, ankle swelling, muscle aches, indigestion or bruising. His home readings over the past week average 136/82. He has had no stroke symptoms. He had the echocardiogram this morning. He signed a weekly lease for his room and is waiting for his benefits decision. [S]

ElementDetail
Home blood pressureAverage 136/82 over the past week
Medicine effectsMore morning urination; no dizziness, cramps, swelling, muscle aches or bleeding
Stroke symptomsNone
SocialRoom settled; benefits decision pending

Review of Systems

SystemResultFinding
CardiovascularNegativeNo chest pain or ankle swelling
NeurologicalNegativeNo weakness, numbness, speech trouble, or dizziness on standing
MusculoskeletalNegativeNo muscle aches or cramps
GastrointestinalNegativeNo indigestion or black stools

4 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Hydrochlorothiazide 25 mg tablet, one tablet by mouth each morningonce daily in the morningOral route1930-07-21 to 1930-09-29completedS
Amlodipine 5 mg tablet, one tablet by mouth dailyonce dailyOral route1930-07-21activeS
Atorvastatin 40 mg tablet, one tablet by mouth dailyonce dailyOral route1930-07-21activeS
Aspirin 81 mg delayed-release tablet, one tablet by mouth dailyonce dailyOral route1930-07-21activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1930-08-18Body height175cmS
1930-08-18Body weight75.4kgS
1930-08-18Body mass index (BMI) [Ratio]24.6kg/m2S
1930-08-18Systolic blood pressure138mm[Hg]S
1930-08-18Diastolic blood pressure84mm[Hg]S
1930-08-18Heart rate70/minS
1930-08-18Respiratory rate14/minS
1930-08-18Body temperature36.6CelS
1930-08-18Oxygen saturation in Arterial blood by Pulse oximetry97%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1930-08-18Sodium [Moles/volume] in Serum or Plasma136mmol/L136-145 mmol/LNormalS
1930-08-18Potassium [Moles/volume] in Serum or Plasma3.6mmol/L3.5-5.1 mmol/LNormalS
1930-08-18Creatinine [Mass/volume] in Serum or Plasma1.02mg/dL0.74-1.35 mg/dLNormalS
1930-08-18Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1925)/1.73 sq M82mL/min/{1.73_m2}60 or moreNormalS

Physical Exam

Vital signs recorded on 1930-08-18; see the Vital Signs section. [S]

SystemFinding
GeneralWell; blood pressure 138/84, pulse 70, weight 75.4 kg; no drop on standing
NeckSoft right carotid bruit, unchanged
CardiovascularRegular rhythm; no ankle edema

Problems

ProblemClinical statusVerificationCodeProvenance
Elevated blood pressure at the first visit, 166/94 mmHg (average of two seated readings), without a previous diagnosis of hypertension; no symptoms; out-of-office confirmation with a week of home readings requestedresolvedconfirmed R03.0S — Synthetic presenting finding at re-entry; superseded by the diagnosis at the second visit.
Essential hypertension, stage 2, confirmed by home readings averaging 154/90 mmHg; no left ventricular hypertrophy on ECG; urine albumin normalactiveconfirmed I10S — Synthetic modern diagnosis made at the second visit.
Right carotid bruit heard at the first visit in a man with no symptoms of stroke or transient ischemic attack; carotid duplex ultrasound and vascular neurology consultation requestedresolvedconfirmed R09.89S — Synthetic examination finding; superseded by the duplex result at the second visit.
Asymptomatic atherosclerotic stenosis of the right internal carotid artery, 50 to 69 percent by duplex ultrasound, with less than 50 percent plaque on the left; no stroke or transient ischemic attack; managed with best medical therapy (blood pressure control, a statin and low-dose aspirin) and yearly duplex surveillanceactiveconfirmed I65.21S — Synthetic modern diagnosis made at the vascular neurology consultation; not a claim about his real arteries.
Recent release from about six years of incarceration: re-entering community life on parole at 65, establishing primary care with no medical records yet received, a rented room, no earned income, and a public reputation he feels as a burdenactiveconfirmed Z65.2S — Synthetic modern social problem anchored to his documented imprisonment and parole.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
ExaminationOffice blood pressure, seated, average of two readingsEvery visitCompleted today138/84 mmHg
Self-managementHome blood pressure monitoringAt diagnosis and after each treatment changeCompleted todayAverage 136/82 over the past week
LaboratorySodium, potassium, creatinine and eGFRBaseline; early after starting a diuretic or an ARB; then every 6 monthsCompleted todaySodium 136, potassium 3.6 mmol/L, creatinine 1.02 mg/dL, eGFR 82, four weeks after starting hydrochlorothiazide
LaboratoryLipid panelBaseline; 4 to 12 weeks after starting a statin; then every 3 to 12 monthsDueDue at the next visit, ten weeks after starting atorvastatin
ImagingEchocardiogramAt diagnosis of stage 2 hypertensionCompleted todayNo left ventricular hypertrophy; ejection fraction about 60 percent; mild aortic sclerosis
Medication safetyDiuretic effects: orthostatic symptoms, cramps, sodium and potassiumEarly after starting, then every visitCompleted todayNo orthostatic drop; sodium and potassium low-normal
Medication safetyAntiplatelet adherence and bleedingEvery visitCompleted todayTaking aspirin daily; no bleeding or indigestion
Medication safetyStatin adherence and muscle symptomsEvery visitCompleted todayNo muscle symptoms
Self-managementStroke warning signs (BE FAST) and calling 911Every visitCompleted todayNo symptoms; knows the signs
Self-managementRe-entry social needs: housing, income, benefits, recordsEvery visit until settledCompleted todayWeekly lease signed; benefits pending

Goal progress:

Guideline basis: 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults (Jones DW, et al. Hypertension 2025;82:e212-e316) (2025); CMID: Clinical Monitoring Intelligence Database, hypertension, hyperlipidemia and stroke/TIA monographs (2026); 2024 Guideline for the Primary Prevention of Stroke: A Guideline From the American Heart Association/American Stroke Association (Bushnell C, et al. Stroke 2024;55:e344-e424) (2024); 2018 AHA/ACC Guideline on the Management of Blood Cholesterol (Grundy SM, et al. Circulation 2019;139:e1082-e1143) (2018)

Follow-up: Twelve-week review in six weeks, with electrolytes, a lipid panel and ALT. Next scheduled visit 1930-09-29: twelve-week review: blood pressure and lipids after a gout flare on hydrochlorothiazide; switch to losartan. [S]